An
annual conference targeting individuals actively engaged clinically
or scientifically in diagnostic and therapeutic radiology,
oncology, surgery, gynecology, family practice and genetics.
Program
Description The optimal management of breast
cancer is rapidly evolving. A multidisciplinary team of medical,
surgical and radiation oncologists, pathologists, plastic surgeons
and genetic counselors are routinely involved in offering treatment
recommendations for individual patients with a diagnosis of breast
cancer. With the emergence of prevention strategies, women at high
risk of developing breast cancer are now evaluated for medical therapies,
surgical options and lifestyle changes that may reduce their risk
of developing breast cancer. The 10th Annual Lynn Sage Breast Cancer
Symposium provides a forum for discussing and presenting laboratory
and clinical research concerning the care of patientswith breast
cancer.
Educational Objectives
At the conclusion of this symposium, participants should be able to:
• Identify new treatment strategies for managing
cancer-associated pain, learn to communicate compassionately and
honestly about disease status and understand ways to manage the
long–term side effects of adjuvant therapy in breast cancer
survivors.
• Describe controversies regarding different
HER2 testing methods, understand recent data regarding new prognostic
and predictive molecular and clinical markers, identify implications
of a diagnosis of lobular carcinoma in situ and describe the issues
following a core needle biopsy diagnosis of breast cancer.
• Describe and understand the optimal systemic
therapy to reduce the risk of recurrence in patients with early
stage breast cancer
• Describe the advances made in identifying
patients with genetic abnormalities that increase risk for developing
breast cancer.
• Describe and understand the reconstructive
surgical options available to patients with early
stage breast cancer.
• Describe and understand the gene expression
patterns in tumor tissue that correlate with response or resistance
to anti-cancer therapies.
• Describe the potential benefits and risks
of partial breast irradiation techniques.